Biogen Inc. (BIIB) Financials
BIIB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 26.6 billion | 11.4 billion |
2023-12-31 | 26.8 billion | 12.0 billion |
2023-09-30 | 28.2 billion | 13.7 billion |
2023-06-30 | 25.2 billion | 10.7 billion |
BIIB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 432.3 million | 72.8 million |
2023-12-31 | -52.7 million | 54.9 million |
2023-09-30 | 504.8 million | 62.2 million |
2023-06-30 | 400.0 million | 71.5 million |
BIIB Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2024-03-31 | 393.4 million |
2023-12-31 | 248.9 million |
2023-09-30 | -68.3 million |
2023-06-30 | 593.3 million |
BIIB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 1.1 billion | - | 406.5 million |
2023-12-31 | 1.0 billion | - | 400.0 million |
2023-09-30 | 2.3 billion | - | 428.8 million |
2023-06-30 | 6.1 billion | 6.3 billion | 304.4 million |
BIIB Shares Outstanding
BIIB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 120.9 million | 383.6 million | 581.5 million | - |
2023-12-31 | 65.2 million | 570.9 million | 537.1 million | 71.4 million |
2023-09-30 | 87.6 million | 736.3 million | 788.2 million | - |
2023-06-30 | 87.0 million | 584.2 million | 548.0 million | - |
BIIB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 2.2 billion | 689.8 million |
2023-12-31 | 2.4 billion | 618.3 million |
2023-09-30 | 2.5 billion | 659.6 million |
2023-06-30 | 2.5 billion | 592.7 million |
BIIB
Price: $216.13
52 week price:
Earnings Per Share: 7.97 USD
P/E Ratio: 24.23
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 789100
Ebitda: 1.6 billionMarket Capitalization: 31.3 billion